President Trump’s executive order, which threatens pharmaceutical companies with targeted retaliation and lawsuits if they fail to lower drug prices, raises serious legal questions and could create drug shortages if implemented. Despite its flaws, the order recognizes a crucial problem. Americans pay disproportionately to subsidize pharmaceutical innovation, while the rest of the world benefits and pays […]
Author Archives: Satya Marar
Satya Marar is a a visiting postgraduate fellow at the Mercatus Center at George Mason University. He wrote this for InsideSources.com.
